American Epilepsy Society/Congress of Neurological Surgeons Epilepsy Surgery Clinical Practice Guideline
This practice guideline from the American Epilepsy Society (AES) and the Congress of Neurological Surgeons (CNS) provides evidence-based recommendations for surgical treatment of epilepsy for adults and children. It is an update to previous practice parameters published by the Academy of Neurology in 2003. The multidisciplinary panel addressed resective procedures for mesial temporal epilepsy (MTLE), neocortical epilepsy, and resection/disconnection of hypothalamic hamartoma. It also examined evidence for callosotomy in developmental and epileptic encephalopathies. It did not intentionally address neurostimulation treatment. A comprehensive literature review was conducted using the Grading of Recommendations Assessment, Development and Education (GRADE) methodology, and GRADE was also used for decision-making. This guideline considers not only seizure outcomes but also other critical and important outcomes. Seizures, quality of life, mortality, adverse events, and verbal memory loss were considered critical outcomes, while other neuropsychological deficits besides verbal memory loss (ie, naming, fluency), neuropsychiatric, and social outcomes were considered important outcomes. Following the GRADE process, the following strong recommendation was made based on a moderate level of evidence: (1) anterior temporal lobectomy (ATL) is recommended for people with MTLE at low risk for cognitive decline. Due to very low to low certainty of evidence the panel suggested the following conditional recommendations: (1) ATL for people with MTLE at high risk for cognitive decline, (2) selective amygdalo-hippocampectomy (SAH) in MTLE, (3) laser interstitial thermal therapy (LITT) in MTLE, (4) neocortical resection in neocortical epilepsy, and (5) callosotomy in people with drop attacks, Lennox-Gastaut Syndrome (LGS) or developmental and epileptic encephalopathies. The panel recognized that conditional recommendations need to account for individual patient circumstances and mandate shared decision-making to ensure that decisions align with each person's values and preferences. For hypothalamic hamartoma, the panel strongly recommended LITT despite low levels of evidence due to a paradigmatic situation where open surgery has significant risks that outweigh the benefits. If LITT is not available, the panel suggested radiosurgery for hypothalamic hamartoma (conditional recommendation). The panel highlighted that every person with drug-resistant epilepsy should have access to a tertiary epilepsy care center that performs surgical procedures and advanced epilepsy diagnostics (good practice statement).
Authors
- Taylor Duda (ORCID: https://orcid.org/0000-0002-4092-4721)
- Douglas R. Nordli (ORCID: https://orcid.org/0000-0002-3995-5467)
- Mei Bou Nasif (ORCID: https://orcid.org/0000-0003-2713-7894)
- Jorge Alvaro Gonzalez-Martinez (ORCID: https://orcid.org/0000-0002-9936-7034)
- Melissa Lannon (ORCID: https://orcid.org/0000-0003-2691-2692)
- Shannon Hart (ORCID: https://orcid.org/0000-0002-0251-1184)
- Robert A. McGovern (ORCID: https://orcid.org/0000-0003-0752-1899)
- Shawna L Strickland (ORCID: https://orcid.org/0000-0003-2113-0835)
- Barbara C. Jobst (ORCID: https://orcid.org/0000-0001-9243-2238)
- Mohamad Ali Kesserwan (ORCID: https://orcid.org/0000-0002-1593-0740)
- Guy Mead McKhann (ORCID: https://orcid.org/0000-0002-9695-3564)
- Yetiani Roldán (ORCID: https://orcid.org/0009-0009-4564-5973)
- Robyn M. Busch (ORCID: https://orcid.org/0000-0002-5442-4912)
- Amanda Martyniuk (ORCID: https://orcid.org/0000-0002-7307-185X)
- Golbarg T. Saber
- John David Rolston (ORCID: https://orcid.org/0000-0002-8843-5468)
- Howard L. Weiner (ORCID: https://orcid.org/0000-0003-0203-9681)
- David F. Bauer (ORCID: https://orcid.org/0000-0003-3548-0887)
- Dennis D. Spencer (ORCID: https://orcid.org/0000-0002-1276-0467)
- Alexandra Eid (ORCID: https://orcid.org/0000-0001-9983-5793)
- Andrea J. Darzi (ORCID: https://orcid.org/0000-0002-2498-1697)
- Gregory Kent Bergey (ORCID: https://orcid.org/0000-0001-7895-7564)
- Jerome Engel (ORCID: https://orcid.org/0000-0001-6324-5716)
- Jennifer L. Hopp (ORCID: https://orcid.org/0000-0002-2326-0740)
- Aatif M. Husain (ORCID: https://orcid.org/0000-0001-7954-1755)
- James L. Bernat (ORCID: https://orcid.org/0000-0003-1128-0442)
- David S. Gloss (ORCID: https://orcid.org/0000-0002-2215-3564)
- Christopher Saouda (ORCID: https://orcid.org/0000-0002-0025-9050)
- Victoria Vinarsky
- Dina Ghandour (ORCID: https://orcid.org/0000-0001-6069-3353)
- Sunjay Sharma
- Angela Price (ORCID: https://orcid.org/0000-0001-8120-1055)
- Richard Shane
Institutions
- Northwestern University (US)
- University of Maryland, Baltimore (US)
- University of Minnesota (US)
- Cleveland Clinic (US)
- Harvard University (US)
- Johns Hopkins University (US)
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- Baylor College of Medicine (US)
- George Washington University (US)
- Columbia University Irving Medical Center (US)
- Johns Hopkins Medicine (US)
- University of Minnesota System (US)
- Ronald Reagan UCLA Medical Center (US)
- UCLA Medical Center (US)
- Yale University (US)
- University of Chicago (US)
- NeuroMedical Center (US)
- American Epilepsy Society (US)
- Duke Medical Center (US)
- Dartmouth Health (US)
- Mass General Brigham (US)
- Rush University (US)
- The University of Texas Southwestern Medical Center (US)
- McMaster University (CA)
Publication Details
- Journal
- Epiliepsy currents/Epilepsy currents
- Published
- 2026-10-26
- DOI
- https://doi.org/10.1177/15357597261465347
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Epilepsy Society